
Company Info
Year Established2022
Contacts
Kevin Marks, Ph.D.President & CEO
Company Description
Delphia Therapeutics is pioneering an entirely new field of cancer biology – activation lethality – to advance a new treatment paradigm and improve the lives of cancer patients.